Aastrom Biosciences Inc (NASDAQ:ASTM)

CAPS Rating: 1 out of 5

The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.

Recs

0
Player Avatar flrs81 (< 20) Submitted: 5/2/2011 10:37:29 PM : Outperform Start Price: $2.82 ASTM Score: -24.47

waiting for the phase 3 results, go ASTM

Featured Broker Partners


Advertisement